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Abstract
Background: Verbal autopsy (VA) is used to estimate the causes of death in areas with incomplete vital
registration systems. The King and Lu method (KL) for direct estimation of cause-specific mortality fractions (CSMFs)
from VA studies is an analysis technique that estimates CSMFs in a population without predicting individual-level
cause of death as an intermediate step. In previous studies, KL has shown promise as an alternative to physician-
certified verbal autopsy (PCVA). However, it has previously been impossible to validate KL with a large dataset of
VAs for which the underlying cause of death is known to meet rigorous clinical diagnostic criteria.
Methods: We applied the KL method to adult, child, and neonatal VA datasets from the Population Health Metrics
Research Consortium gold standard verbal autopsy validation study, a multisite sample of 12,542 VAs where gold
standard cause of death was established using strict clinical diagnostic criteria. To emulate real-world populations
with varying CSMFs, we evaluated the KL estimations for 500 different test datasets of varying cause distribution.
We assessed the quality of these estimates in terms of CSMF accuracy as well as linear regression and compared
this with the results of PCVA.
Results: KL performance is similar to PCVA in terms of CSMF accuracy, attaining values of 0.669, 0.698, and 0.795
for adult, child, and neonatal age groups, respectively, when health care experience (HCE) items were included. We
found that the length of the cause list has a dramatic effect on KL estimation quality, with CSMF accuracy
decreasing substantially as the length of the cause list increases. We found that KL is not reliant on HCE the way
PCVA is, and without HCE, KL outperforms PCVA for all age groups.
Conclusions: Like all computer methods for VA analysis, KL is faster and cheaper than PCVA. Since it is a direct
estimation technique, though, it does not produce individual-level predictions. KL estimates are of similar quality to
PCVA and slightly better in most cases. Compared to other recently developed methods, however, KL would only
be the preferred technique when the cause list is short and individual-level predictions are not needed.
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In settings where a non-negligible proportion of the
population dies outside of the hospital system, verbal
autopsies (VAs) are emerging as a vital tool for under-
standing the population-level patterns of cause-specific
mortality fractions (CSMFs). By combining this with
robust information on levels of age-specific all-cause
mortality (also collected through household surveys, e.g.,
of sibling survivorship), it is possible to estimate age-
and cause-specific mortality rates. Most population-level
estimates derived from VAs are created in two phases,
by first assigning a cause or several causes to each death
and then calculating CSMFs from the number of deaths
or partial deaths assigned to each cause. Direct estima-
tion is an alternative approach that produces popula-
tion-level estimates of CSMFs directly from the VAs
without the intermediate stage that requires assigning
deaths to each VA. The direct estimation method pro-
posed by King and Lu (which we will call the KL
method) is designed to capture complex patterns of
interdependence between various signs and symptoms
in the VA instrument [1,2]. This approach can be inter-
preted as a sophisticated multiclass generalization of the
classic back-calculation approach of epidemiology and
has been shown to be a promising method in theoretical
simulation and small-scale validation studies [2].
The KL method is based on the following matrix
expression:
P(S) = P(S|D) × P(D)
2k × 12 k × nn × 1
Where P(S) is the distribution of symptom profiles in
the test dataset, P(S|D) is the distribution of symptom
profiles for each cause of death (calculated using the
training dataset), and P(D) is the distribution of causes
of death in the test dataset. A symptom profile is a com-
bination of k different symptoms. Each symptom is
dichotomous, so k symptoms yield 2
k symptom profiles.
P(S)a n dP(S|D) are calculated by tabulation. For a
symptom profile s0, P(S = s0) is calculated by counting
the fraction of VAs to be analyzed that endorse symp-
tom profile s0. For a symptom profile s0 and cause j, P(S
= s0|D = j) is calculated by counting the fraction of VAs
in the “training set” with disease j as the cause of death
that endorses symptom profile s0. Quadratic program-
ming or least squares appro a c h e sm a yb eu s e dt os o l v e
this equation. King and Lu reported that the expected
value of CSMFs estimated by their direct estimation
method in repeated samples yields plausible CSMFs in a
simulation study using data for 13 adult causes of death
in China and 11 causes of child death in Tanzania. King
and Lu [1] further stress that the direct CSMF estima-
tion approach does not depend on the presence in the
VA instruments of items with high sensitivity or specifi-
city for particular causes. They argue the approach pro-
vides an efficient, low-cost approach for estimating
CSMFs and they derive analytical strategies for choosing
symptoms from an instrument that will optimize perfor-
mance. At least two studies have taken the KL method
and applied it to real-world verbal autopsy datasets [3,4].
Despite the impressive results with small errors in
CSMFs reported by King and Lu, there are several out-
standing issues that need to be understood before wide-
spread adoption of the method. First, King and Lu
report in repeated experiments the expected value of
the CSMF produced by their method compared to the
true CSMFs using test and train datasets. They do not
report a metric of the average error in CSMFs across
repeated experiments, leaving it unclear how well the
method will work in a given real-world application. Sec-
ond, in all of the cases that they report, the CSMF com-
position of the train and test datasets are either identical
or very close to each other. The performance of the KL
method when the CSMF composition of the training set
is different than the test dataset has not been estab-
lished. Third, the validation data reported by King and
Lu pertain to relatively short cause lists of length 11 and
13, respectively. The performance of the KL method for
the longer cause lists desired in most VA studies has
not yet been established. Fourth, until recently [5] there
have been no standardized metrics to compare the per-
formance of different VA methods for the estimation of
CSMFs, limiting the comparison of KL to other methods
such as PCVA, InterVA, Symptom Pattern, or others
[6-8].
In this paper we present the results of a validation
study of the KL method, using a large dataset with a
realistically diverse cause list collected in the Population
Health Metrics Research Consortium (PHMRC) gold
standard verbal autopsy validation study [9]. The study
was undertaken to develop a range of new analytical
methods for verbal autopsy and to test these methods
using data collected in six sites in four countries (Mex-
ico, Tanzania, India, and the Philippines). The study is
unique, both in terms of the size of the validation data-
set (7,836, 2,075, and 2,631 deaths in adults, children,
and neonates respectively) and the use of rigorously
defined clinical diagnostic criteria for a death to be
included in the study as a gold standard cause of death.
The dataset collected through the PHMRC is sufficiently
l a r g et ob ea b l et oe x p l o r et h er e l a t i o n s h i pb e t w e e n
CSMF errors by cause and overall CSMF accuracy and
the size of training and test datasets.
Methods
We use the PHMRC gold standard VA dataset to under-
take three distinct analyses to understand the
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Details of the methods used for establishing the gold
standard cause of death and for the collection of the VA
data are reported elsewhere in detail [9]. The PHMRC
instrument uses separate modules for neonate, child,
and adult deaths so these sets of deaths have been ana-
lyzed separately. The final cause lists are mutually exclu-
sive and collectively exhaustive for all causes, and
contain 11 causes for neonates, 21 causes of child death,
and 34 causes of adult death. The development of train-
ing and test datasets is described in detail elsewhere [9]
and is summarized in Figure 1.
Figure 1 outlines the basic simulation design to gener-
ate a range of test and training datasets. First, for each
cause we split the data randomly without replacement,
with 75% into a training set and 25% into a test set.
This step was repeated 500 times to avoid results being
influenced by the idiosyncrasies of a particular data
split. We then sampled CSMF compositions from an
uninformative Dirichlet distribution and randomly
resampled (with replacement) the available deaths in the
test set to generate a test dataset with the prescribed
total number of deaths and CSMF composition. By vary-
ing the CSMF compositions of test datasets as well as
the total number of deaths, we generated a wide array
of validation datasets. Each one maintained a strict
separation of training and test data, which guarantees
that our metrics are for “out-of-sample” prediction qual-
ity. This method generates test/train datasets with inde-
pendent CSMF composition.
O v e rt h ec o u r s eo ft h eP H M R Cg o l ds t a n d a r dV A
validation study, it became clear that metrics for gauging
the quality of VA methods are quite subtle and are not
standardized between research efforts. The complex
issues are described fully by Murray et al. [5], who also
proposed new metrics that allow for quality comparison
across cause lists and cause compositions. Following
their recommendations, we report median CSMF accu-
racy across 500 test datasets. At the cause-specific level
we report the intercept, slope, and root mean squared
error (RMSE) for the relationship between estimated
CSMF and the true CSMF assessed using linear
regression.
Murray et al. [10] showed that in China, the recall of
the household or possession of medical records recorded
in the VA interview had a profound effect on both the
concordance for PCVA as well as the performance of
the computer-coded VAs. However, obtaining useful
information from this health care experience (HCE) can-
not be assumed for many settings where VA will be
used. Therefore, we identified all signs and symptoms
that we suspected could be much more informative for
people who have received health care and performed all
validation experiments on two versions of the datasets
developed above, one with all variables (noted as with
HCE) and one version excluding recall of health care
experience (without HCE).
Validating KL CSMFs for neonates, children, and adults
In the first test, we apply the KL software to the 500
pairs of training and test datasets for each of the three
age groups. We assess the performance of the KL
method by reporting median CSMF accuracy and the
relationship between the estimated CSMFs and true
Original Data with 
Validated Gold Standard
Train Dataset
Test Data Pool
Random 
CSMF via 
Dirichlet
Test Dataset
KL Direct Estimation of CSMFs
Sampling 
without 
replacement
75%
25%
Sampling with 
replacement
True CSMFs Comparison Accuracy
Figure 1 The process of generating 500 test and train datasets
and applying KL estimation to them. After dividing the whole
dataset into 25% testing and 75% training portions (randomly,
stratified by cause), a draw from an uninformative Dirichlet
distribution was used to perturb the cause combination of the test
set (by resampling each cause with replacement according to a
CSMF that was drawn from Dirichlet distribution). Accuracy of the
KL method was calculated by comparing the KL-estimated CSMFs
and the true CSMF of the test dataset.
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select two parameters: the number of symptoms to be
subset from all symptoms (nSymp), and the total num-
ber of draws of different subsets (n.subset). For these
main results, we used settings of 10 symptoms and 400
iterations.
We also investigated the effect of these parameters on
the accuracy of the KL method by an extensive explora-
tion of the range of settings. We repeated our assess-
ment while varying the nSymp from eight to 18. We
also varied n.subset from 200 to 600.
Assessing the relationship between KL CSMF accuracy
and the number of causes
To evaluate the dependence of the method’sC S M F
accuracy on the number of causes in the cause list, we
performed the following experiment. For n =5 ,6 ,. . . ,4 6
we randomly chose n causes of death and used a CSMF
drawn from an uninformative Dirichlet to construct a
test dataset that contains exactly n causes of death. (The
maximum is 46, as our original adult dataset has 46
causes of death.) The deaths were sampled from the ori-
ginal 25% test and 75% train pool datasets described
above. We performed 500 iterations for each n.B yt h e
nature of this test, the number of deaths in the train
and test datasets do not vary as the number of causes
are altered. This provides a direct assessment of perfor-
mance strictly as a function of the number of causes.
Assessing if KL accuracy is influenced by the correlation
between training and test dataset CSMF composition
The technique described for the experiments above gen-
erates test and training sets that have independently
random CSMFs. We suspected that the KL performance
in previous studies has been exaggerated because the
CSMF compositions of test and train datasets have been
similar. To investigate this hypothesis, we conducted an
additional analysis using training and test sets generated
by sampling deaths from training and test pools uni-
formly at random (with replacement). In contrast to
previous experiments in which the CSMFs of the test
and train datasets are independent, the test and train
datasets in this case both have CSMF combinations
similar to those of the original pool. The same metrics
are used for this assessment.
Results
CSMF accuracy of KL for adult, child, and neonatal VA
analysis was found to be largely independent of using
different sized symptom clusters and including or
excluding HCE (Table 1 and Figure 2). For all experi-
ments, n.subset of KL method, which specifies the total
number of draws of different subsets of symptoms, is set
to 400. Through our experiments we saw no significant
variation in the CSMF estimation accuracy by changing
the symptom cluster size when n.subset is large enough
(greater than 200). Figure 2 shows the variation of
CSMF accuracy when the symptom cluster size is varied
between eight and 18. (The KL method requires that
the number of causes in the module be fewer than the
number of symptom profiles 2
k. Hence, theoretically k =
6 is the smallest allowed. In addition, since some symp-
tom profiles never appear in the data, k = 8 is the smal-
lest nSymp we could use for all adult, child, and neonate
datasets.)
As shown in Table 1, without HCE the KL method
slightly outperforms PCVA. We remark that the PCVA
accuracy for child VAs in absence of HCE variables is
0.05 below the median KL accuracy. For neonatal VAs
without and with HCE variables, the KL method CSMF
accuracy is 0.797 (95% uncertainty interval [UI]: 0.784,
0.805) and 0.795 (0.783, 0.806), respectively, which are
also substantially higher than than CSMF accuracy of
PCVA.
The relationship between estimated and true CSMFs
for each cause in adults, children, and neonates are
shown in Additional file 1. A good estimation should
have intercept close to zero and slope close to one.
With slope 0.631, intercept 0.015, and RMSE 0.013,
drowning is the most accurately estimated cause of
death in adult VA. In the same module, stomach cancer
and other cardiovascular diseases are the least accurately
estimated causes with slope being approximately 0.08.
Other cardiovascular disease also has a high intercept
(0.047), which shows it is substantially overestimated
when the true CSMF is low. In the child module, violent
death is the most accurately estimated CSMF with slope
0.480, intercept 0.024, and RMSE 0.016, and other
digestive disease is the worst estimated cause where
slope, intercept, and RMSE are 0.092, 0.031, and 0.010,
respectively. In the neonatal module, stillbirth is almost
perfectly estimated with slope, intercept, and RMSE
being 0.98, 0.003, and 0.017, respectively. Pneumonia
has the lowest accuracy of estimation with a slope,
intercept, and RMSE of 0.199, 0.053, and 0.026. As it is
observed, the quality of prediction is generally higher in
Table 1 Median CSMF Accuracy for KL and PCVA, by age
group with and without HCE
KL PCVA
Median 95% UI Median 95% UI
Adult No HCE 0.661 (0.654, 0.665) 0.624 (0.619, 0.631)
HCE 0.669 (0.664, 0.673) 0.675 (0.669, 0.680)
Child No HCE 0.687 (0.682, 0.692) 0.632 (0.626, 0.642)
HCE 0.698 (0.692, 0.702) 0.682 (0.671, 0.690)
Neonate No HCE 0.797 (0.784, 0.805) 0.695 (0.682, 0.705)
HCE 0.795 (0.783, 0.806) 0.733 (0.719, 0.743)
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which estimation is not accurate, KL tends to assign
close to constant cause fractions, which results in higher
intercepts and lower slopes. As a result, small CSMFs
are overestimated and large CSMFs are underestimated
in such causes.
We found that in adult VA, the KL method is most
effective in predicting CSMF for maternal causes and
causes that are due to injuries, such as drowning. In
child VA, measles, malaria, bite of venomous animal,
and violent death were most accurately predicted. For
neonatal VA, stillbirth and preterm delivery cause group
were best. In contrast, KL performs poorly in predicting
stomach cancer and other noncommunicable disease in
adults, other digestive disease and other infectious dis-
ease in children, and pneumonia in neonates.
As shown in Table 1, in general, the effect of the HCE
variable on the accuracy of CSMF estimation is not large
(the change is 0.008, 0.011, and -0.002 for adult, child, and
neonates). For the majority of causes in all age groups,
accuracy slightly increased when HCE variables were
added; however, the change was not large. For example, in
the adult module, average slope increases from 0.236 to
0.247 and average intercept decreases from 0.024 to 0.023
(mean RMSE does not change).
Figures 3, 4, and 5 show the estimated and true CSMF
of a selection of causes in the three age groups. A lower
slope in the regression shown in Additional file 1 shows
more deviation from the perfect estimation line in the
figures. We found that KL tends to equally distribute
deaths among causes, which overestimates the CSMF
w h e nt h et r u eC S M Fi sv e r yl o wa n du n d e r e s t i m a t e s
when it is high.
A ss h o w ni nF i g u r e6 ,t h en u m b e ro fc a u s e so nt h e
cause list has a very large impact on the accuracy of KL
CSMF estimations. While these results are acquired by
randomly dropping causes from the adult module, a
comparison with the neonate and child modules’ accu-
racy results (Table 1) suggests that the most important
parameter in the KL method’s superior performance in
child and neonate modules is the lower number of
causes in these modules. Accuracy is above 0.75 when
the cause list contains fewer than 12 causes. For larger
cause lists, such as those used for practical applications
in adults and children, the KL method generates pro-
gressively lower levels of CSMF accuracy.
We found that KL is extremely sensitive to the level of
similarity between cause composition in the train and
test datasets. We observed that if both test and train
sets are randomly sampled with the same cause
0.5
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Figure 2 Variation of CSMF accuracy of the KL method as a function of symptom cluster size (nSymp). For all age groups, with and
without HCE, varying the symptom cluster size had little effect on CSMF accuracy.
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Page 5 of 10composition, KL estimation will yield dramatically
higher CSMF accuracy. For example, for adult VAs with
HCE when the test and train set have the same CSMF,
the median CSMF accuracy is 0.947 (0.945, 0.951),
which is 0.28 points higher than the accuracy of KL for
redistributed test sets and within 0.05 of the maximum
possible accuracy.
Discussion
In this first large-scale validation of the KL method for
direct CSMF estimation compared to gold standard
cause of death assignment, we found that the method
performs about as well as PCVA in terms of CSMF
accuracy. Compared with some new methods [8,11,12],
KL generates substantially less accurate CSMFs for
adults and children. The KL method yields CSMF esti-
mates that tend to be biased upwards when the true
CSMFs in the test datasets are low and biased down-
wards when the true CSMFs are high. The extent of
t h e s eb i a s e si sh i g h l yv a r i a b l ea c r o s sc a u s e s .T h eb i a s e s
in the KL estimates of CSMFs bear considerable resem-
blance to the biases observed in PCVA by cause,
although there is some variation in performance by
cause.
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Figure 3 Estimated versus true cause fractions for AIDS, maternal, pneumonia, and drowning in adults in 500 random resamplings of
the validation dataset. Causes like pneumonia were overestimated when rare but underestimated when common, while causes like drowning
were estimated with accuracy that does not depend closely on true cause fraction.
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details of the method. First, we found that varying
symptom cluster size from eight to 18 made essentially
no difference to the results. Second, KL does well in
estimating CSMFs for causes such as road traffic acci-
dents and drowning for which there are sensitive and
specific symptoms. These are the same causes on which
physicians also perform well. Our experiments show
that, similarly to individual-level cause assignment tech-
niques, KL is inaccurate in finding CSMFs for causes
with weak symptom presence. Where there is not a
clear set of sensitive and specific symptoms, the KL
method tends to yield CSMF estimates that are biased
towards the cause fraction in the training dataset rather
than the test dataset. This tendency of the KL method
to project the training dataset CSMF onto the test data-
set is confirmed by the experiment in which we found
that KL accuracy was exaggerated when the training and
test datasets have identical CSMF compositions.
One clear advantage of KL compared to PCVA is in
the tests in which household recall of health care experi-
ence is excluded from physician review and the KL
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Figure 4 Estimated versus true cause fraction for AIDS, malaria, pneumonia, and violent death in children in 500 random resamplings
of the validation dataset. These causes were underestimated when rare and overestimated when common.
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expected to have little exposure to health care, the KL
approach should be preferred to PCVA. This finding,
however, must be tempered with the comparison to
other methods (Symptom Pattern, Tariff, and Machine
Learning) that all have better performance than KL in
the absence of household recall of health care
experience.
The relatively disappointing performance of KL com-
pared to published claims will surprise some readers. The
key explanation is the number of causes included in our
study for adults and children. Our finding that the KL
method’s accuracy dramatically decreases as the number
of causes increases explains why KL has performed well
in previous validation studies (e.g., [2]). These have all
used lists of causes that contain fewer than 15 causes. For
studies with smaller number of causes (e.g., neonatal VA
studies usually consider fewer than eight to 10 causes of
deaths) our findings suggest that the KL method pro-
duces very good results with a CSMF accuracy greater
than 0.75. A further reason for the exaggerated perfor-
m a n c ep r e v i o u s l yr e p o r t e df o rK Lm a yb et h a tp r e v i o u s
studies used test and train datasets that had similar
CSMF compositions. Our experiments here show that
the KL method in this special case yields substantially
higher levels of CSMF accuracy. In real populations,
there is no reason to expect that a training dataset col-
lected in a hospital will have the same CSMF composi-
tion as the population. In fact, a method that largely
returns the training dataset CSMF composition adds little
information beyond the CSMF composition of the train-
ing dataset. Thus, a more realistic assessment of KL per-
formance follows from the cases in which the CSMF
compositions in the test and train datasets are unrelated.
A central assumption of the KL approach is that, con-
ditional on the cause of death, the symptom profiles of
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Figure 5 Estimated versus true cause fraction for stillbirth and pneumonia in neonates in 500 random resamplings of the validation
dataset. Stillbirth estimations were highly accurate, while pneumonia was either underestimated or overestimated in most cases.
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Figure 6 Median CSMF accuracy versus number of causes on a
cause list for the KL method. The test datasets for this experiment
were generated by randomly selecting a set of causes and
constructing test datasets using an uninformative Dirichlet
distribution. The KL method has excellent performance for short
cause lists, but rapidly degrades as the length of the list increases.
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community deaths. The data in the PHMRC study was
collected from deaths that met stringent gold standard
diagnostic criteria, and most of these necessarily occur
within the hospital system (community deaths simply
cannot meet the diagnostic criteria for many causes). As
a result, this validation study cannot directly investigate
the importance of this assumption to the KL method.
However, by excluding HCE variables from the study,
we have emulated this setting and found little change to
our results.
Conclusion
Our validation of the KL method for direct estimation
of CSMF from VA data collected in the PHMRC study
showed that KL performs at about the same level as
PCVA for adults, slightly better for children, and
much better for neonates. Since it is a direct method,
it does not yield cause of death assignments for indivi-
dual deaths. We also found that KL performance is
sensitive to the number of causes on the cause list,
and as the number of causes under consideration
increases, the quality of KL estimation decreases preci-
pitously. This degradation is especially relevant when
using VA to understand population-level patterns of
adult mortality, in which the accuracy of KL becomes
comparable to PCVA. Thus we judge KL to be a rea-
sonable approach for neonatal VA and other settings
with very short cause lists, but not as useful in its cur-
rent form for adult or child VA. For adults and chil-
dren, other methods, such as the Simplified Symptom
Pattern, Random Forest, and Tariff, have better CSMF
accuracy and also provide individual death cause
assignment.
Additional material
Additional file 1: Slope, intercept, and RMSE from linear regression
of estimated versus true CSMFs, by age group and cause with and
without HCE.
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